Aims To test the hypothesis that Qr in V 1 is a predictor of pulmonary embolism, right ventricular strain, and adverse clinical outcome. Methods and Results ECG's from 151 patients with suspected pulmonary embolism were blindly interpreted by two observers. Echocardiography, troponin I, and probrain natriuretic peptide levels were obtained in 75 patients with pulmonary embolism. Qr in V 1 (14 vs 0 in controls; p<0.0001) and ST elevation in V 1 ≥1 mV (15 vs 1 in controls; p=0.0002) were more frequently present in patients with pulmonary embolism. Sensitivity and specificity of Qr in V 1 and T wave inversion in V 2 for predicting right ventricular dysfunction were 31/97% and 45/94%, respectively. Three of five patients who died in-hospital and 11 of 20 patients with a complicated course, presented with Qr in V 1 . After adjustment for right ventricular strain including ECG, echocardiography, pro-brain natriuretic peptide and troponin I levels, Qr in V 1 (OR 8.7, p=0.02) remained an independent predictor of adverse outcome. Conclusions Among the ECG signs seen in patients with acute pulmonary embolism, Qr in V 1 is closely related to the presence of right ventricular dysfunction, and is an independent predictor of adverse clinical outcome.
Introduction
Electrocardiography (ECG) in patients with pulmonary embolism may show several abnormalities related to right ventricular strain. Many ECG signs are more frequent in patients with pulmonary embolism compared to those in whom pulmonary embolism is suspected but excluded, but none of the different ECG signs have been shown to be sufficiently specific to establish the diagnosis. In combination with a high clinical pretest probability or echocardiographic signs of right ventricular dysfunction, accuracy of ECG to diagnose pulmonary embolism may be improved. 1, 2 On the other hand, ECG may be entirely normal in up to 20% of patients with pulmonary embolism resulting in a low sensitivity for the exclusion of the diagnosis. 3 However, ECG is obtained in almost all patients who present with dyspnoea, chest pain or syncope. Thus, its diagnostic value for patients with suspected pulmonary embolism is important even in the era of modern diagnostic strategies including spiral computed tomography (CT) and echocardiography.
Many years ago, Weber and Phillips observed a pseudoinfarction pattern with Q waves in lead V 1 in 10 of 60 patients with pulmonary embolism. 3 This pattern was also found in 11 of 90 patients with pulmonary embolism in a later study. 4 It is assumed that this sign is caused by massive right-heart dilatation rotating the QRS vector away from the V 1 -position resulting in a Q wave. We aimed to test the hypothesis that Qr in V 1 is a the predictor of pulmonary embolism, right ventricular strain, and adverse clinical outcome.
Methods

Patients
A total of 151 consecutive patients from a diagnostic and treatment study with suspected symptomatic pulmonary embolism from the emergency department were enrolled in the present analysis. 5 The study protocol was approved by the local ethics committee, and written informed consent was obtained from all patients.
Diagnostic strategy
The diagnostic strategy included D-dimer testing, assessment of clinical pretest probability according to the Wells criteria, 6 and spiral computed tomography (CT). In 30 patients with a D-dimer level below the cut-off value (500 ng/ml) and a low pretest probability, pulmonary embolism was excluded. In the remaining 121 patients with elevated D-dimer, including two patients with a negative D-dimer but a moderate or high pretest probability, spiral CT was performed. Pulmonary embolism was confirmed in 75 patients by spiral CT. In 34 patients with a negative spiral CT and a low clinical pretest probability, pulmonary embolism was excluded. In 12 patients with a negative spiral CT but a moderate or high pretest probability, further diagnostic tests were obtained: ventilation perfusion scan in six, compression sonography of the leg veines in four, and pulmonary angiography in two patients. According to the strategy, 75 patients were positive and 76 negative for pulmonary embolism.
Discharge diagnoses of the 76 patients without pulmonary embolism were musculoskeletal pain (n=22), pneumonia (n=17), chronic obstructive lung disease (n=15), congestive heart failure (n=14), acute coronary syndrome (n=2), pericardial effusion (n=2), aortic dissection (n=2), and sepsis (n=2). Three-month follow-up was performed in the 76 patients with initially negative test results. There was no venous thromboembolism among these patients, including 70 patients who received no anticoagulation during follow-up.
Laboratory tests
D-dimer was measured in all patients on admission using VIDAS D-dimer (bio-Mérieux, France), a quantitative enzyme-linked immunoassay automated on a VIDAS immunoanalyzer. 7 Troponin I and Nterminal pro brain natriuretic peptid (proBNP) levels were taken in all 75 patients with pulmonary embolism on admission. Troponin I was measured using a microparticle enzyme immunoassay (Abbott, USA), and proBNP with the Elecsys 2010 immunoassay analyzer (Roche, Germany). A Troponin I level ≥0.6 ng/ml was considered to be elevated. 
Spiral computed tomography (CT)
Pulmonary embolism was diagnosed by spiral CT when there was at least one intravascular filling defect in a pulmonary artery using a standard protocol. 9 A single-slice CT scanner Somatom Plus 4 UFC (Siemens, Erlangen, Germany) was used in 80 patients, and a multislice scanner Asteion MS (Toshiba, Tokyo, Japan) in 41 patients. The scan protocol with the single slice scanner included early arterial phase scanning 15-20 s after powerinjection of a bolus of 120 ml of a contrast agent with 300 mg/ml iodine content using a 3 mm collimation, pitch 1.5, and a 2 mm reconstruction interval with coverage of the lung vasculature, followed by a second portal venous phase scan with 8 mm collimation and 8 mm reconstruction interval, pitch 1.5, covering the entire chest. The standard protocol of the multislice scanner included arterial phase scanning 20 s after powerinjection of a 120 ml bolus of the contrast agent with 4|31 mm collimation, pitch 5.5/4 and 1 mm reconstruction interval with coverage of the entire chest. The interobserver agreement between two radiologists for spiral CT results was 97% (kappa 0.95, p<0.0001).
Transthoracic echocardiography
Echocardiography was performed in all patients with pulmonary embolism using an Acuson Sequoia TM C256 system (Mountain View, California, USA) with a 3.5 MHz probe and 3-lead electrocardiographic monitoring within 4 h after admission. Echocardiographic off-line analysis by soft-copy reading was performed by a cardiologist who was unaware of clinical data. Systolic right ventricular dysfunction was diagnosed in the presence of moderately to severely depressed right ventricular free wall kinesis.
10,11
Electrocardiography (ECG)
Twelve-lead ECG was obtained in all 151 patients with suspected pulmonary embolism at admission. ECG's were independently interpreted by two observers blinded to patient data. Following ECG signs were investigated: Heart rate >100 beats per minute, rightward shift of QRS axis >50°, Qr in V 1 , S 1 subtypes (S 1 Q 3 /S 1 rSr# 3 /S 1 S 2 S 3 ), incomplete and complete right bundle branch block (RBBB), clockwise rotation of the QRS vector in the precordial leads (CLOCKROT) defined as R=S in V 4 , V 5 or V 6 , T wave inversion in V 2 or V 3 (T NEG V 2 ), ST elevation in V 1 ≥0.1mV (ST POS V 1 ), and atrial fibrillation or flutter. 3, 4, 12, 13 The criteria for the diagnosis of Qr in V 1 were the presence of a prominent Q wave of ≥0.2 mV and a ventricular depolarisation <120 ms (Fig. 1) .
Statistical analysis
Kappa measurement was performed to examine interobserver agreement for ECG signs and spiral CT findings, respectively. Stepwise logistic regression was performed with univariately significant ECG signs (Table 1) to find the best model to predict or exclude pulmonary embolism. ProBNP levels in the presence or absence of ECG signs were compared with the Mann-Whitney u-test. Multivariate logistic regression analysis was performed to investigate the accuracy of ECG signs for predicting 'escalation of therapy' defined as the need for cardiopulmonary resuscitation, mechanical ventilation, pressors, thrombolysis, catheter fragmentation, or surgical embolectomy according to the MAPPET-3 criteria.
14 Following univariately significant variables were included in the multivariate analysis: Qr in V 1 , T NEG V 2 , Troponin I ≥0.06 ng/ml, proBNP ≥500 pg/ml, and moderate to severe right ventricular systolic dysfunction. Differences in mortality and 'escalation of therapy' according to the presence or absence of ECG signs were analyzed using Fisher's exact two-sided test.
Results
ECG and pulmonary embolism diagnosis
Interobserver agreement was accurate for most ECG signs (Table 2) . Agreement for the presence or absence of S 1 subtypes and clockwise rotation of the QRS vector in the precoardial leads was moderately accurate. None of the patients with excluded pulmonary embolism had a Qr in V 1 resulting in a specificity and sensitivity of 100% and 19%, and a positive and negative predictive value of 100% and 55%, respectively. Sinus tachycardia, S 1 subtypes, incomplete RBBB, T NEG V 2 , and ST POS V 1 were more frequently present in patients with pulmonary embolism (Table 1) . None of the ECG signs was sufficiently sensitive to exclude pulmonary embolism. The accuracy to predict or exclude pulmonary embolism was improved by the combination of Qr in V 1 , ST POS V 1 , S 1 subtypes, and incomplete RBBB resulting in a specificity and sensitivity of 91% and 47%, respectively.
ECG signs in relation to right ventricular strain and clinical outcome in patients with pulmonary embolism
Moderate to severe right ventricular systolic dysfunction by echocardiography was present in 42 patients with pulmonary embolism. Elevated Troponin I levels were found in 25 patients with pulmonary embolism. Nine of 14 patients with Qr in V 1 and 10 of 15 patients with ST POS V 1 had a troponin I level ≥0.6 ng/ml (Table 3 ). Significant differences in proBNP levels were found for Qr in V 1 , iRBBB, CLOCKROT, and T NEG V 2 (Fig. 2) . Qr in V 1 and T NEG V 2 were most specific for the prediction of right ventricular dysfunction, and S1 subtypes most sensitive for the exclusion of right ventricular dysfunction compared with other ECG signs (Table 4) .
In patients with a shock index ≥1 (heart rate divided by systolic blood pressure) and right ventricular dysfunction, thrombolysis was performed in six and surgical embolectomy in four patients. Thrombolysis was also administered in six patients with a shock index <1 and right ventricular dysfunction. Heparin alone was given in the remaining 59 patients of whom 26 had right ventricular dysfunction but contraindications for thrombolysis according to the guidelines of the European Society of Cardiology. 15 Five of the 75 patients with pulmonary embolism died in-hospital from right ventricular failure. Twenty patients had 'escalation of therapy' including the need for at least one of the following: cardiopulmonary resuscitation (n=3), mechanical ventilation (n=4), pressors (n=7), thrombolysis (n=12), embolectomy (n=4). In patients with 'escalation of therapy', systolic blood pressure was lower (89±27 vs 122±19 mmHg; p=0.011), and heart rate higher (114±20 vs 85±17 beats per minute; p=0.023) compared to patients without the need for 'escalation of therapy'.
Qr in V 1 was present in three (60%) of the five patients who died from right ventricular failure, and it was present in only 11 of 67 (16%) surviving patients (Table 5) . Compared with other ECG signs, sinus tachycardia, Qr in V 1 and T NEG V 2 also predicted 'escalation of therapy'. Sensitivity, specificity, negative and positive predictive value of Qr in V1 for predicting 'escalation of therapy' were 55%, 95%, 85% and 79%, respectively. In a multivariate regression analysis including the ECG signs Qr in V 1 and T NEG V 2 , results of echocardiography and biomarker tests, Qr in V1 (OR 8.7, 95%CI 1.4-56.7; p=0.02), proBNP levels ≥500 pg/ml (OR 12.5, 1.2-135.2; p=0.04), and Troponin I levels ≥0.06 ng/ml (OR 7.7, 1.6-36.5; p=0.01) remained independent predictors of adverse clinical outcome. Sensitivity, specificity, negative and positive predictive value of the combination of these prognostic markers for the prediction of 'escalation of therapy' were 75%, 91%, 75% and 91%, respectively.
DISCUSSION ECG and pulmonary embolism diagnosis
The present study of 151 patients with suspected PE confirms previous reports that ECG alone is not sufficient to exclude pulmonary embolism. [2] [3] [4] 16 Sensitivity and specificity of ECG to predict pulmonary embolism even in combination of different ECG signs (i.e. Qr in V 1 , ST POS V 1 , S 1 subtypes, and incomplete RBBB) was 47% and 91%, respectively. The prevalence of Q waves in V 1 among patients with pulmonary embolism in the present study 3, 4 Due to a lack of a control group in the above mentioned studies, no statement about the diagnostic accuracy of this ECG sign was possible. In the present study, none of the 76 patients with excluded PE presented with a Qr in V 1 resulting in a specificity and positive predictive value of 100%, respectively.
ECG signs in relation to right ventricular strain and clinical outcome in patients with pulmonary embolism
The relation of ECG signs indicating right ventricular strain with haemodynamic data is well documented. 4, [17] [18] [19] In 90 patients with pulmonary embolism, those with pseudoinfarction pattern (29±3 mmHg) and right axis deviation (31±7 mmHg) had highest mean pulmonary artery pressure values. 4 In a study of 80 patients with pulmonary embolism, T NEG V 2 was associated with severely increased mean pulmonary artery pressure (37±8 mmHg) compared with the other ECG signs. 17 In the present study, QR in V 1 and T NEG V 2 were most closely related to the presence of moderate to severe right ventricular dysfunction.
Pulmonary artery pressure is probably not the best outcome predictor because it depends on dynamics of embolic events, right ventricular systolic function and volume status. Thus, patients with chronic recurrent pulmonary embolism will probably tolerate higher pulmonary artery pressure values than those with a single massive embolic event. Novel and probably more accurate predictors of right ventricular dysfunction include markers of minor myocardial injury (cardiac troponins) and increased myocardial shear stress (b-type and atrial natriuretic peptides). [20] [21] [22] [23] In the present study, ST POS V 1 and Qr in V 1 were the only ECG signs associated with the presence of a troponin I leak. High proBNP levels were found in patients with Qr in V 1 , T NEG V 2 , incomplete RBBB, and clockwise rotation of the QRS vector in the precordial leads.
Qr in V 1 was associated with increased early mortality. Three of five patients who died inhospital from right ventricular failure initially presented with this sign. In addition, Qr in V 1 and T NEG V 2 were highly associated with an increased risk of 'escalation of therapy' including the need for cardiopulmonary resuscitation, mechanical ventilation, pressors, thrombolysis, or embolectomy. After adjustment for the emerging markers of right ventricular strain including ECG signs, echocardiographic findings, troponin I and proBNP levels, Qr in V1 remained an independent predictor of 'escalation of therapy'.
Despite interpretation of negative spiral CT scans in context with clinical pretest probability, and the absence of venous thromboembolism among 46 patients with initially negative test results during follow-up, pulmonary embolism could have been present in a few cases. This might have caused overestimation of sensitivity of the ECG signs, thus making it even lower than reported in the present study.
Conclusion
Qr in V 1 is highly specific for pulmonary embolism although its prevalence among consecutive patients with suspected pulmonary embolism is low. Compared with other ECG signs, Qr in V 1 is the strongest predictor of right ventricular dysfunction, and it is highly associated with troponin leakage and myocardial shear stress. Qr in V 1 and the presence of negative T waves in V 2 or V 3 also predict a complicated hospital course and therefore, are useful for risk stratification in pulmonary embolism. In patients with suspected acute pulmonary embolism, presenting with one of these ECG signs, more intensive hospital resources should be allocated to allow for a rapid diagnostic approach including echocardiography to confirm right ventricular dysfunction.
